Navigation Links
Dr. Ken Kaitin, Tufts CSDD, Keynotes Preclinical Conference
Date:8/25/2011

BOSTON, Aug. 25, 2011 /PRNewswire/ -- CBI, a division of Advanstar Communications, is pleased to announce that Dr. Ken Kaitin, Director of the Tufts Center for the Study of Drug Development and Research Professor at Tufts University School of Medicine, is the keynote speaker at their Pharma/Bio Forum on Preclinical Development. The conference is being held September 26-27, 2011 at the Hyatt Harborside in Boston, MA. Dr. Kaitin will review today's research and development landscape and discuss how companies are restructuring to maximize efficiency and boost productivity.

Key success factors for many leading pharmaceutical companies include: alliances and partnerships, understanding the challenges of academic-industry relationships and leveraging translational science. Dr. Kaitin will share insight on the changing environment for preclinical development and new models of innovation. Learn more about Dr. Kaitin's keynote presentation here.

The recently announced Pfizer innovation center in Boston is just one example of how pharma plans to increase R&D efficiency and lower expenses by teaming up with local hospitals and academic research institutions for innovative drug discovery and translational R&D. Conference presentations designed specifically for those leading innovation in preclinical development include: Best methods for selecting and contracting with a CRO, understand oversight, management and quality challenges with global outsourcing, how to effectively partner with academic institutions, In-licensing and out-licensing - what both sides need to know.

For more information, please call 800-817-8601 or to view the entire agenda please visit http://www.cbinet.com/preclinical or review the agenda. To apply for a press pass, please contact Lauren Donoghue: lauren.donoghue@cbinet.com.

Event Sponsors include Toxikon and MPI Research.

About CBI

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 3 Tufts engineering faculty earn prestigious national awards for promising research
2. The Jackson Laboratory and Tufts University Announce New Ph.D. Track in Mammalian Genetics
3. Tufts Launches Institute for Biopharmaceutical Partnerships
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
6. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
7. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
8. Covance Decides to Pursue Its Original Preclinical Strategy in China
9. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
10. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
11. NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):